Cure First is combining breakthroughs in functional genomics, high-throughput screening and bioinformatics in order to rapidly pinpoint the unique vulnerabilities of different cancer cells. Ultimately, this will allow us to analyze individual tumors, one by one, and to select the most specific and effective treatment for each patient. This targeted approach to cancer therapy promises to be less toxic and more personalized than any we have seen before.
A New Project Sweetheart Initiative
Cure First is taking an ovarian cancer project to the next phase with the testing of newly identified drug combinations on avatar mice. Read more about this promising effort and how you can help support this critical work:
HELP FUND our VISION
Cure First was founded in response to cutbacks in research funding at a time when exciting new technologies in the fight against cancer were emerging. Our goal was to push forward with the discovery of new drug targets. Cure First continues in this mission and depends on the support of philanthropic organizations, private donors and the generosity of corporate sponsors.